Services
How we support biotech & pharma teams
We help biotech and pharma teams make confident decisions about targets, indications, and patient selection using human genetics and real-world evidence.
Target prioritization
Integrate genetics and RWE to clarify which targets to advance, which indications to prioritize, and where development risk is highest across your portfolio.
Trial enrichment
Identify responder subgroups and design enrichment strategies using multi-omics and ML. Production models with automated testing, versioning, and drift monitoring.
How we work
Simple, focused engagements
Define
Align on the decision, available data, and success criteria.
Analyze
Integrate genetics, multi-omics, and RWE into clear recommendations.
Deliver
Decision memo with evidence pack in 4–5 weeks.
Project-based (4–8 weeks) or advisory retainer.